Systemic Therapy Selection is a clinical decision-making process that identifies and prioritizes pharmacological interventions for metastatic cancer based on their ability to target disseminated tumor cells throughout the body, distinguished from localized treatment strategies by its focus on comprehensive, organism-wide antineoplastic activity.
740
Publications
53.5K
Citations
5.9K
Authors
1.7K
Institutions
Publications per year
2017–2026
360
Parents
Publications
740
Systemic Therapy for Colorectal Cancer
Jeffrey A. Meyerhardt, Robert J. Mayer · New England Journal of Medicine · 2005 · 1.1K citations
Medicine, Oncology, Pharmacology +17
1–5 of 740
Authors
5.9K
- AB
10
h-index
- AP
8
h-index
- SD
7
h-index
- MK
7
h-index
- JL
7
h-index
1–5 of 5.9K
Institutions
1.7K
The University of Texas MD Anderson Cancer Center
Houston, United States
45 h-index
277 publications
39.1K citations
Memorial Sloan Kettering Cancer Center
New York, United States
42 h-index
209 publications
37.1K citations
Fox Chase Cancer Center
Philadelphia, United States
28 h-index
48 publications
16.6K citations
Moffitt Cancer Center
Tampa, United States
28 h-index
40 publications
14.3K citations
University of Colorado Denver
Denver, United States
27 h-index
93 publications
24.8K citations
University of Utah
Salt Lake City, United States
27 h-index
63 publications
15.9K citations
Massachusetts General Hospital
Boston, United States
26 h-index
67 publications
10.1K citations
Dana-Farber Brigham Cancer Center
Boston, United States
26 h-index
58 publications
14K citations
1–8 of 1.7K
Venues
- Journal of Clinical Oncology
54 publications · 6.6K citations
31
h-index
- Journal of the National Comprehensive Cancer Network
29 publications · 12.5K citations
29
h-index
- PubMed
Repository · 64 publications · 2.2K citations
26
h-index
- Cancer
37 publications · 3K citations
26
h-index
- Cancers
12 publications · 329 citations
12
h-index
1–5